# KYNMOBI
> **NDA210875** · New Drug Application · Sponsor: SUMITOMO PHARMA AM · Approved 2020-05-21
## Drug
- **FDA Application Number:** NDA210875
- **Application type:** New Drug Application
- **Brand name:** KYNMOBI
- **Generic name:** Apomorphine Hydrochloride
- **Active ingredients:** APOMORPHINE HYDROCHLORIDE
- **Dosage form:** FILM
- **Route:** SUBLINGUAL
- **Marketing status:** Discontinued
- **Sponsor:** SUMITOMO PHARMA AM
- **First approval:** 2020-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210875)
---
*MORVS · CC0 1.0*